Park Therapeutics' mission is to develop new treatments that revolutionize the management of pain, by bringing new drugs to the market that are safer and more effective with less addiction potential

Park Therapeutics was formed with the primary purpose of developing new drugs to improve the treatment of pain. We recognize the dual crises in the United States both from the overuse of prescription opioids leading to abuse and addiction, as well as the need for better therapies to manage the large and increasing number of patients with significant pain.  Our goal is to develop new drugs that will be part of the solution to each problem.